Danaher's $5.7B Abcam Buy Gets The Green Light To Close
The multibillion-dollar deal between health care tech conglomerate Danaher Corp. and life sciences research tools company Abcam PLC, first announced in August, is expected to close Dec. 6 after receiving clearance...To view the full article, register now.
Already a subscriber? Click here to view full article